MacroGenics
MGNX
127 hedge funds and large institutions have $593M invested in MacroGenics in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 19 closing their positions.
488% more call options, than puts
Call options by funds: $7.8M | Put options by funds: $1.33M
35% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 37
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.04% less ownership
Funds ownership: 96.08% → 95.04% (-1%)
2% less funds holding
Funds holding: 130 → 127 (-3)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
25% less capital invested
Capital invested by funds: $796M → $593M (-$203M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$10.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.44M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$4.21M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$3.17M |
| 5 |
BlackRock
New York
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$12.6M |
| 2 |
State Street
Boston,
Massachusetts
|
-$10.6M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.23M |
| 4 |
Man Group
London,
United Kingdom
|
-$2.75M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.66M |
MGNX Hedge Fund Activity: Q3 2019 in Review
127 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2019, worth a combined $593M — down 25% from $796M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of MGNX and 16 opened new positions — a net loss of 3 holders — while 37 trimmed existing stakes and 50 added.
The largest buyer was Bellevue Group, adding an estimated $10.5M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $12.6M sold.
- 127 institutional investors held MacroGenics (MGNX) as of Q3 2019, down from 130 in Q2 2019.
- Funds reported $593M of MacroGenics stock for Q3 2019, down 25% quarter-over-quarter.
- 16 funds opened new MacroGenics positions in Q3 2019 and 19 closed out, a net change of -3 holders.
- The largest MacroGenics buyer in Q3 2019 was Bellevue Group, an estimated $10.5M added.
- The largest MacroGenics seller in Q3 2019 was Lord, Abbett & Co, an estimated $12.6M sold.
Based on aggregated 13F filings for Q3 2019.